Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of April 6, 2026, Akebia Therapeutics Inc. (AKBA) trades at a current price of $1.35, marking a recent daily change of -1.81%. This analysis covers key market context, technical support and resistance levels, and potential near-term scenarios for the biotech stock, with a focus on observable market signals rather than speculative forecasts. No recent earnings data is available for AKBA as of the date of publication, so this analysis prioritizes trading activity and technical trend signals. Re
Is Akebia (AKBA) Stock a Value Play | Price at $1.35, Down 1.81% - Breakout Watch
AKBA - Stock Analysis
4660 Comments
1051 Likes
1
Camerina
Daily Reader
2 hours ago
US stock options flow analysis and unusual options activity tracking to identify smart money positions in the market. Our options intelligence reveals hidden bets and sentiment indicators that often precede major price moves.
๐ 136
Reply
2
Airel
Loyal User
5 hours ago
I donโt know what this is, but it matters.
๐ 244
Reply
3
Timarion
Elite Member
1 day ago
Investor caution is evident, as volume spikes are followed by quick profit-taking.
๐ 146
Reply
4
Xannon
Insight Reader
1 day ago
Missed itโฆ oh well. ๐
๐ 88
Reply
5
Dward
Loyal User
2 days ago
This activated nothing but vibes.
๐ 173
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.